Comparative Effectiveness of Probiotics, Prebiotics, and Synbiotics for Symptoms of Autism Spectrum Disorder: A Systematic Review and Network Meta-analysis

Clicks: 11
ID: 337377
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Emerging

Ranked #43 of 50 articles by views in nutrition reviews

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
CONTEXT: Autism spectrum disorder (ASD) is characterized by impaired social interaction, communication deficits, and repetitive behaviors. Increasing evidence suggests that gut microbiota may be a potential therapeutic target. However, the relative efficacy of single-strain probiotics, multistrain probiotics, prebiotics, and synbiotics remains unclear. OBJECTIVE: This network meta-analysis aims to systematically compare the effectiveness of these microbiota-targeted interventions on ASD symptoms. DATA SOURCES: A systematic search of PubMed, Embase, Web of Science, Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov was conducted up to June 20, 2025. DATA EXTRACTION: Randomized controlled trials (RCTs) assessing single-strain probiotics, multistrain probiotics, prebiotics, or synbiotics in individuals with ASD were included. The primary outcome was the improvement in deficits in core ASD symptoms, such as social communication and interaction and restricted and repetitive behaviors, which were assessed using standardized tools. DATA ANALYSIS: A Bayesian network meta-analysis with random-effects modeling was performed. Seventeen RCTs involving 904 participants were included. Synbiotics showed greater efficacy in improving ASD symptoms compared with placebo (standardized mean difference [SMD]: -1.90; 95% credible interval [CrI]: -2.66 to -1.06), prebiotics (SMD: -2.23; 95% CrI: -3.10 to -1.06), multistrain probiotics (SMD: -1.59; 95% CrI: -2.41 to -0.68), and single-strain probiotics (SMD: -1.52; 95% CrI: -2.40 to -0.60). The sensitivity analyses were generally consistent with the primary findings. CONCLUSION: Synbiotics appeared to demonstrate greater efficacy than probiotics, prebiotics, and placebo in improving behavioral symptoms of ASD. However, given the limited available evidence and modest sample sizes, this finding should be interpreted cautiously and considered preliminary. SYSTEMATIC REVIEW REGISTRATION: PROSPERO registration No. CRD420251078170.
Reference Key
openalex_W7223895166 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shiyu Zhang, Yushun Yan, Min Wang, Jinxue Wei, Xiaohong Ma, Yang Xiao
Are you one of these authors? Claim your profile
Journal nutrition reviews
Year 2026
DOI
10.1093/nutrit/nuag159
URL
https://doi.org/10.1093/nutrit/nuag159
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.